Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-25

Clinical Trial Update: Faecal Microbiota Transplantation in Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating fecal microbiota transplantation for ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Faecal Microbiota Transplantation

Snippet

Sponsor: The University of New South Wales | Conditions: Ulcerative Colitis, Inflammatory Bowel Disease | Phase 2 | Status: COMPLETED